GLP-1 Microdosing: What It Means and the Evidence
App Library Tools Pricing Download
[Glossary · Protocol words]

Microdosing (GLP-1 microdosing)

Also called micro-dosing, GLP-1 microdose, low-dose GLP-1 · Reviewed

Definition: Microdosing, for GLP-1 drugs, means taking much less than the label starting dose, or spacing doses further apart. A 2026 review describes it as 25-50% of the starting dose or longer gaps between shots. It is an off-label community practice, not a dose on any label.

What the evidence says

A 2026 commentary in Expert Opinion on Pharmacotherapy says high-quality evidence is essentially absent. Reports so far are anecdotes and real-world accounts of less nausea and modest weight loss. A 2026 nurse practitioner report flags dosing errors, pen manipulation and compounded vials as safety risks.

On ClinicalTrials.gov we found two registered randomized trials of GLP-1 microdosing, one recruiting and one enrolling by invitation. As of October 2026 neither has posted results, so there are no completed trials of the practice.

Worked example

This shows why small doses are hard to measure. It is arithmetic, not a suggestion.

25-50% of a 0.25 mg starting dose

  1. The Wegovy label starts at 0.25 mg weekly. 25% is 0.0625 mg; 50% is 0.125 mg.
  2. From a vial at 2.5 mg/mL: 0.125 ÷ 2.5 = 0.05 mL, which is 5 units on a U-100 syringe.
  3. 0.0625 ÷ 2.5 = 0.025 mL, which is 2.5 units, a half-mark many syringes do not show.
  4. A half-unit misread at that size is a 20% error.

Why it matters when you track doses

At tiny volumes, small slips become large percentages. Log the dose in milligrams, the vial strength and the units drawn, so a mistake can be found later. Prescription pens are built for set doses; "click counting" a pen is outside its label.

Read more on Dose Track: GLP-1 microdosing: the evidence · GLP-1 units converter · Semaglutide guide

General education drawn from labels and published studies, not personal medical advice. Your prescriber, pharmacist and the label that came with your product are the final word.
Titration (dose escalation)Titration means adjusting a dose in planned steps, usually starting low and going up, until a target or… GLP-1 receptor agonistA GLP-1 receptor agonist is a drug that switches on the same receptor as GLP-1 (glucagon-like peptide-1),… U-100 syringeA U-100 syringe is an insulin syringe marked for insulin that holds 100 units per mL. Each unit mark… Insulin syringe unitsThe units on an insulin syringe are marks of volume. On a U-100 syringe, 1 unit = 0.01 mL; on a U-40… Concentration (mg/mL)Concentration is how much drug is in each unit of volume, usually written as mg/mL, mcg/mL or units/mL. It…

Frequently asked questions

Is GLP-1 microdosing proven to work?+
No. A 2026 review says high-quality evidence is essentially absent. Two randomized trials are registered on ClinicalTrials.gov, but neither had posted results as of October 2026.
What counts as a microdose?+
A 2026 review describes it as 25-50% of the label starting dose, or longer gaps between doses. For a 0.25 mg starting dose that is 0.0625 to 0.125 mg.
Why is microdosing hard to measure?+
The volumes are tiny. 0.0625 mg from a 2.5 mg/mL vial is 2.5 units on a U-100 syringe, so a half-unit misread is a 20% error.

Sources

  1. Beck and Clements. Expert Opin Pharmacother 2026 (considerations and challenges in microdosing GLP-1 drugs). PMID 42788826
  2. Trainer. J Am Assoc Nurse Pract 2026 (the "microdosing" dilemma). PMID 42201545
  3. ClinicalTrials.gov NCT07325500: Incretin microdosing for cardiometabolic health in people with HIV
  4. ClinicalTrials.gov NCT07092605: Effectiveness of microdosed GLP-1 on health, quality of life and longevity measures
  5. Wegovy (semaglutide) US prescribing information, DailyMed

All glossary terms · Goals and conditions · Compound guides · Help center